Surgepays (NASDAQ:SURG) reported quarterly losses of $(0.66) per share. This is a 265 percent decrease over earnings of $0.40 per share from the same period last year. The company reported quarterly sales of $15.086 million which missed the analyst consensus estimate of $15.154 million by 0.45 percent. This is a 57.96 percent decrease over sales of $35.886 million the same period last year.
Surgepays Q2 2024 GAAP EPS $(0.66) Down From $0.40 YoY, Sales $15.086M Miss $15.154M Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.